The potential role of curcumin in prostate cancer: the importance of optimizing pharmacokinetics in clinical studies

Transl Cancer Res. 2016 Nov;5(Suppl 6):S1107-S1110. doi: 10.21037/tcr.2016.11.04.

Authors

Keith T Schmidt¹, William D Figg^{1

2}

Affiliations

¹ Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Publication types

Comment

Grants and funding

Z01 BC010547-05/Intramural NIH HHS/United States